Pharma Pulse 3/7/25: Shaping Trust Through Design, New Interest in Direct Contracting & more

Healthcare’s Visual Future: Shaping Trust Through Design

The six key design trends of 2025 redefine how healthcare brands can inspire trust and build lasting connections with their audiences.

Direct Contracting: Not New, But New Interest

Direct contracting is not a new concept: Cut out the insurers as middlemen and work directly with providers on more integrative health and aligned metrics. But companies are newly exploring different ways to implement it and fully realize the benefits.

Microsoft-OpenAI Partnership Gets UK Antitrust Clearance

The decision is a a victory for the tech giant in its bid to justify the partnership to regulators on both sides of the Atlantic.

Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases

Arrowhead Pharmaceuticals, Inc. announced presentation of preclinical data supporting the advancement of two first-in-class clinical stage, RNAi-based investigational therapeutics being developed for the treatment of obesity and metabolic diseases. The two candidates, ARO-INHBE and ARO-ALK7, have the potential to reduce body weight and fat mass with a novel mechanism of action that may lead to improved preservation of lean muscle mass compared to currently approved obesity therapies.

IQVIA Commercial Solutions on LinkedIn

Evolving technology presents new challenges in engaging HCPs digitally. Discover the latest insights in this new Pharmaceutical Commerce Magazine article by Esther Van Hulten on the importance of advancing HCP engagement tailored to HCP preferences.

Read the article here: https://lnkd.in/dQa6Bqnr

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs